An example of national scientific collaboration during the COVID-19 pandemic: Turkish Thoracic Society Early Career Members Taskforce Group’s contribution to accessing reliable scientific knowledge

Karadoğan, Dilek; Emiralioğlu, Nagehan; Akyıl, Fatma Tokgöz; Gürkan, Canan Gündüz; Yüksel, Aycan; Marım, Feride; Töreyin, Zehra Nur; Arıkan, Hüseyin; Eyüboğlu, Tuğba Şişmanlar; Şerifoğlu, İrem; Sandal, Abdülsamet; Gürsoy, Tuğba Ramaslı; Akgün, Metin

doi:10.18332/popmed/125944

Cited by 2 publications

(1 citation statement)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This included clinical records of COVID-19 patients but also data on acutely relevant resources, such as hospital capacity, staff, personal protective equipment and respirators. Majority of scientific and anecdotal accounts reported increased data sharing and collaboration between clinicians, clinical and public health healthcare organisations, governments and citizens, hospitals and long-term care organisations, and between the public and the private sector in healthcare [30][31][32][33][34][35][36]. However, a knowledge gap exists in understanding the extent, nature and sustainability of these practices from the perspective of mid-level hospital managers in Europe.…”

Section: Introductionmentioning

confidence: 99%

Data-Driven Collaboration between Hospitals and Other Healthcare Organisations in Europe During the COVID-19 Pandemic: An Explanatory Sequential Mixed-Methods Study among Mid-Level Hospital Managers

Ivanković

Garel

Klazinga³

et al. 2023

Int J Integr Care

View full text Add to dashboard Cite

Introduction: Data and digital infrastructure drive collaboration and help develop integrated healthcare systems and services. COVID-19 induced changes to collaboration between healthcare organisations, which previously often happened in fragmented and competitive ways. New collaborative practices relied on data and were crucial in managing coordinated responses to the pandemic. In this study, we explored data-driven collaboration between European hospitals and other healthcare organisations in 2021 by identifying common themes, lessons learned and implications going forward. Methods: Study participants were recruited from an existing Europe-wide community of mid-level hospital managers. For data collection, we ran an online survey, conducted multi-case study interviews and organised webinars. Data were analysed using descriptive statistics, thematic analysis and cross-case synthesis. Results: Mid-level hospital managers from 18 European countries reported an increase in data exchange between healthcare organisations during the COVID-19 pandemic. Data-driven collaborative practices were goal-oriented and focused on the optimisation of hospitals’ governance functions, innovation in organisational models and improvements to data infrastructure. This was often made possible by temporarily overcoming system complexities, which would otherwise hinder collaboration and innovation. Sustainability of these developments remains a challenge. Discussion: Mid-level hospital managers form a huge potential of reacting and collaborating when needed, including rapidly setting up novel partnerships and redefining established processes. Major post-COVID unmet medical needs are linked to hospital care provision, including diagnostic and therapeutic backlogs. Tackling these will require rethinking of the position of hospitals within healthcare systems, including their role in care integration. Conclusion: Learning from COVID-19-induced developments in data-driven collaboration between hospitals and other healthcare organisations is important to address systemic barriers, sustain resilience and further build transformative capacity to help build better integrated healthcare systems.

show abstract

Section: Introductionmentioning

confidence: 99%

Data-Driven Collaboration between Hospitals and Other Healthcare Organisations in Europe During the COVID-19 Pandemic: An Explanatory Sequential Mixed-Methods Study among Mid-Level Hospital Managers

Ivanković

Garel

Klazinga³

et al. 2023

Int J Integr Care

View full text Add to dashboard Cite

show abstract

The use of combined hormonal contraception in the context of the COVID-19 pandemic

et al. 2021

View full text Add to dashboard Cite

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) was declared the cause of a global pandemic in early 2020. Patients with COVID-19 are at high risk for thrombotic occlusions of the arteries and veins. There are many ways that explain the high risk of thrombosis in COVID-19, they are conditionally divided into two main categories: mechanisms in which the renin-angiotensinaldosterone system is involved and mechanisms that affect the regulation of the immune response. It is assumed that the uncomplicated course of the disease is characterized by endothelial dysfunction, but if the process progresses with a pronounced immune response, plasma coagulation factors may also be involved, which significantly increases the risks of thromboembolic complications. The use of combined hormonal contraception (CHC) in the current conditions raises a number of concerns. According to some researchers, disorders of the hemostasis system observed in patients with COVID-19 may worsen while taking CHC and increase the risk of thromboembolic complications, which is especially important in severe disease with prolonged immobilization. However, with the use of CHC, the increase in thrombotic risks is explained primarily by changes in the plasma component of the hemostasis sys tem. At first glance, the recommendations to stop hormone therapy with confirmed COVID-19 seem logical, but they are based only on the procoagulant activity of estrogens, and not on real evidence. In patients with COVID-19, the increase in coagulation is associ ated with massive damage to the vascular endothelium (the so-called «external» coagulation pathway) and the immune response, and not with a primary increase in the level of coagulation factors per se. At the same time, stopping the intake of estrogens deprives the patient of their important protective effect. Thus, it became necessary to develop clinical guidelines for the management of women using contraception in the context of the COVID-19 pandemic.

show abstract

An example of national scientific collaboration during the COVID-19 pandemic: Turkish Thoracic Society Early Career Members Taskforce Group’s contribution to accessing reliable scientific knowledge

Cited by 2 publications

References 4 publications

Data-Driven Collaboration between Hospitals and Other Healthcare Organisations in Europe During the COVID-19 Pandemic: An Explanatory Sequential Mixed-Methods Study among Mid-Level Hospital Managers

Data-Driven Collaboration between Hospitals and Other Healthcare Organisations in Europe During the COVID-19 Pandemic: An Explanatory Sequential Mixed-Methods Study among Mid-Level Hospital Managers

The use of combined hormonal contraception in the context of the COVID-19 pandemic

Contact Info

Product

Resources

About